Entresto 97 MG-103 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FQ89X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,616
Award facts
- Contract value 100% obligated
- $15,615.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,615.57 to AmerisourceBergen Drug Corp for Entresto 97 mg-103 mg tablets (60-count supply) on September 24, 2025, with completion targeted for September 25, 2025. This non-competitive, firm fixed-price delivery order represents a small transaction within the company's broader pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems, with the performance location identified in its home state.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement extending through December 2026. The IDC enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. Entresto, a cardiovascular medication, represents one of many therapeutic categories AmerisourceBergen delivers through this vehicle, which also encompasses specialty medications, vaccines, and medical supplies. The award reflects the company's established capability to fulfill federal medical procurement requirements and its role as a primary pharmaceutical supplier within the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQ89X?
SPE2DB25FQ89X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FQ89X worth?
The government has obligated $15,616 on SPE2DB25FQ89X.
Is contract SPE2DB25FQ89X an order under another contract?
Yes. SPE2DB25FQ89X is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ89X competed?
The extent of competition for SPE2DB25FQ89X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award